Managing blood sugar levels is crucial for individuals with diabetes or those at risk of developing it. While lifestyle changes and proper diet play a significant role, certain medications can also impact blood sugar levels. In this article, we will explore the effects of several common medications on raising blood sugar levels.
Corticosteroids
Corticosteroids, such as prednisone and dexamethasone, are commonly prescribed to reduce inflammation and suppress the immune system. However, they can also increase blood sugar levels by promoting insulin resistance, inhibiting insulin secretion, and enhancing glucose production in the liver (1).
Studies have shown that corticosteroids can lead to impaired glucose tolerance and an increased risk of developing diabetes (2). Monitoring blood sugar levels regularly and adjusting diabetes management strategies may be necessary for individuals taking corticosteroids.
Beta blockers
Beta blockers are commonly prescribed for conditions such as high blood pressure, heart disease, and migraines. While not all beta blockers have a significant impact on blood sugar levels, some non-selective beta blockers, such as propranolol and nadolol, can inhibit the body’s response to hypoglycemia symptoms (3).
These medications can mask the symptoms of low blood sugar, making it more difficult for individuals with diabetes to recognize and treat hypoglycemia promptly. It is important for people with diabetes to work closely with their healthcare providers to find suitable alternatives or adjust their diabetes management plan if beta blockers are prescribed.
Statins
Statins are widely prescribed to lower cholesterol levels and reduce the risk of cardiovascular disease. While the primary focus of statin therapy is on lipid management, studies have shown that some statins, such as atorvastatin and rosuvastatin, may have a modest effect on blood sugar levels (4).
Research suggests that statins can increase insulin resistance and impair pancreatic beta-cell function, leading to a small but increased risk of developing diabetes (5). However, the cardiovascular benefits of statin therapy generally outweigh the potential risks of raised blood sugar levels.
Niacin
Niacin, also known as vitamin B3, is often used to raise high-density lipoprotein (HDL) cholesterol levels and lower triglycerides. However, niacin has been associated with an increased risk of insulin resistance and impaired glucose tolerance (6).
While the effects of niacin on blood sugar levels are not as pronounced as with other medications, individuals with diabetes should monitor their blood sugar closely when taking niacin supplements or prescription medications containing niacin.
Antipsychotics
Certain antipsychotic medications, including clozapine, olanzapine, and risperidone, have been associated with an increased risk of weight gain and the development of diabetes or worsening of glucose control (7).
These medications can contribute to insulin resistance and impair glucose metabolism, potentially leading to elevated blood sugar levels. Regular monitoring of blood sugar and close collaboration between mental health and primary care providers are essential for individuals taking antipsychotics.
Antibiotics
Some antibiotics, such as fluoroquinolones (e.g., ciprofloxacin) and macrolides (e.g., erythromycin), have been associated with a potential increase in blood sugar levels (8).
While the exact mechanisms are not fully understood, studies have suggested that certain antibiotics can interfere with glucose metabolism and impair insulin sensitivity (9).
It is important to note that the overall impact of antibiotics on blood sugar levels is still being investigated, and the effects may vary depending on the individual and specific antibiotic used. If you have diabetes or concerns about the effects of antibiotics on blood sugar levels, it is recommended to discuss them with your healthcare provider.
Decongestants
Decongestants, such as pseudoephedrine and phenylephrine, are commonly used to relieve nasal congestion. While decongestants themselves do not directly affect blood sugar levels, they can have an indirect impact by stimulating the release of stress hormones, such as adrenaline and noradrenaline (10).
These stress hormones can trigger an increase in blood sugar levels by promoting the breakdown of glycogen into glucose and inhibiting insulin release. People with diabetes should be cautious when using decongestants and monitor their blood sugar levels closely to ensure proper management.
Conclusion
It is important to recognize that the impact of medications on blood sugar levels can vary among individuals, and not everyone will experience significant changes. However, understanding the potential effects of common medications on blood sugar levels is essential for individuals with diabetes or those at risk of developing it.
Regular monitoring of blood sugar levels, close collaboration with healthcare providers, and appropriate medication adjustments are crucial to maintaining optimal blood sugar control. If you have any concerns about the effects of specific medications on your blood sugar levels, it is recommended to consult with your healthcare provider for personalized advice and guidance.
REFERENCES:
Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711-1723.
Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007;18(10):1319-1328.
Mogensen UM, Andersson C, Fosbøl EL, et al. Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes—a randomized study. Cardiovasc Diabetol. 2012;11(1):105.
Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735-742.
Culver AL, Ockene IS, Balasubramanian R, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. Arch Intern Med. 2012;172(2):144-152.
Guyton JR, Bays HE, Grundy SM, Jacobson TA. The clinical problem of statin-induced myalgia. Mayo Clin Proc. 2014;89(6):879-902.
Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86(1-3):15-22.
Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis. 1999;28(2):352-364.
Wiersinga WJ, Bonten MJ, Boersma WG Leibovitz A. The use of fluoroquinolones in children. Curr Opin Pediatr. 2010;22(1):81-85.
Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Effect of phenylpropanolamine and caffeine on substrate utilization in obese and lean Zucker rats. Pharmacotherapy. 1997;17(4):748-757.